Delivery Order SPE2DB20D1004-SPE2DB23FG0Y3

Award Date 6/20/23
Potential Completion Date 6/21/23
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen injections to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,131.76 and an ultimate completion date of November 9, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pens to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,493.13 contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen subcutaneous injections to the Defense Logistics Agency (DLA), a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,106.01 and an ultimate completion date of December 22, 2021. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen medication to the Defense Logistics Agency (DLA). The contract, valued at $20,655.64, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pens to support federal healthcare requirements. The award, valued at $20,961.44, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order with an ultimate completion date of January 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen SML to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 26, 2022, with a ceiling value of $2,321.72 and an ultimate completion date of August 29, 2022. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen to the Defense Logistics Agency (DLA), a major component of the U.S. Department of Defense responsible for providing logistics support to the military. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a firm-fixed-price delivery order with a ceiling value of $5,972.52 and a completion date of December 30, 2021. The contract does not have a set-aside...
This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen medication to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,112.70 and was awarded on August 11, 2021 with an ultimate completion date of August 12, 2021. The contract is a delivery order under a larger Indefinite...
This federal contract award is for the procurement of Cosentyx 75 mg/0.5 ml syringes from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,460.73 delivery order was placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, with a performance period ending on December 20, 2023. The contract is a firm-fixed price Delivery Order issued under the DLA's Indefinite Delivery Contract (IDC) with Cencora, Inc., valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cosentyx 300 mg dose-2 pen syringes. The contract has a ceiling value of $6,004.32 and runs through May 19, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG0Y3
    Delivery Order

This federal contract award is for the delivery of Cosentyx 300 mg dose-2 pen injectors to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,521.95, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company.

The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:27 AM